- Home
- BTO vs MLAB Comparison
BTO vs MLAB Comparison
Compare BTO & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTO
- MLAB
- Stock Information
- Founded
- BTO 1994
- MLAB 1982
- Country
- BTO United States
- MLAB United States
- Employees
- BTO N/A
- MLAB N/A
- Industry
- BTO Investment Managers
- MLAB Industrial Machinery/Components
- Sector
- BTO Finance
- MLAB Industrials
- Exchange
- BTO Nasdaq
- MLAB Nasdaq
- Market Cap
- BTO 670.7M
- MLAB 680.0M
- IPO Year
- BTO N/A
- MLAB N/A
- Fundamental
- Price
- BTO $34.51
- MLAB $103.99
- Analyst Decision
- BTO
- MLAB Hold
- Analyst Count
- BTO 0
- MLAB 2
- Target Price
- BTO N/A
- MLAB $130.00
- AVG Volume (30 Days)
- BTO 54.2K
- MLAB 70.8K
- Earning Date
- BTO 01-01-0001
- MLAB 08-04-2025
- Dividend Yield
- BTO 9.13%
- MLAB 0.62%
- EPS Growth
- BTO N/A
- MLAB N/A
- EPS
- BTO N/A
- MLAB N/A
- Revenue
- BTO N/A
- MLAB $240,978,000.00
- Revenue This Year
- BTO N/A
- MLAB $6.73
- Revenue Next Year
- BTO N/A
- MLAB $5.49
- P/E Ratio
- BTO N/A
- MLAB N/A
- Revenue Growth
- BTO N/A
- MLAB 11.47
- 52 Week Low
- BTO $22.95
- MLAB $83.68
- 52 Week High
- BTO $32.81
- MLAB $155.12
- Technical
- Relative Strength Index (RSI)
- BTO 59.80
- MLAB 41.29
- Support Level
- BTO $33.70
- MLAB $96.54
- Resistance Level
- BTO $34.50
- MLAB $102.52
- Average True Range (ATR)
- BTO 0.55
- MLAB 4.63
- MACD
- BTO -0.07
- MLAB -1.02
- Stochastic Oscillator
- BTO 68.48
- MLAB 29.03
About BTO John Hancock Financial Opportunities Fund
John Hancock Financial Opportunities Fund is the United States based closed-end, diversified management investment company. Its investment objective is to provide a high level of total return consisting of long-term capital appreciation and current income. The company invests in banks, capital markets, Insurance, Mortage Real Estate Investment trust, Health Care REITs, Diversified REITs, Office REITs.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.